Platelets at the interface between hemostasis and innate immunity

Transfusion Medicine and Hemotherapy

Volumn 31, Issue 6, 2004, Pages 379-386

  Kehrel, Beate E ^a   Jurk, K ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cationic antimicrobial peptides; Host defense; Inflammation; Leukocytes; Platelets

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA LYSIN; BETA THROMBOGLOBULIN; CD40 ANTIGEN; CD40 LIGAND; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; INTERLEUKIN 8; LYSINE; NEUTROPHIL ACTIVATING PEPTIDE 2; RANTES; THROMBOCIDIN 1; THROMBOCYTE FACTOR 4; THYMOSIN BETA4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; B LYMPHOCYTE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; HEMOSTASIS; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NONHUMAN; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 18044395386     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082482     Document Type: Review

References (79)

1. Levin J: The evolution of mammalian platelets; in Michelson AD (ed): Platelets. San Diego, Academic Press, 2000, pp 3-19.
2. Muta T, Iwanaga S: The role of hemolymph coagulation in innate immunity. Curr Opin Immunol 1996;8:41-47.
3. Janeway CA, Travers P, Walport M, Shlomchik M (eds): Immunobiology. New York, Churchill Livingston, 2001.
4. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
5. Tang YQ, Yeaman MR, Selsted ME: Antimicrobial peptides from human platelets. Infect Immun 2002; 70:6524-6533.
6. Yeaman MR, Bayer AS: Staphylococcus aureus, platelets, and the heart. Curr Infect Dis Rep 2000;2: 281-298.
7. Zlotnik A, Yoshie O: Chemokines: A new classification system and their role in immunity. Immunity 2000;12:121-127.
8. Yeaman MR, Tang YQ, Shen AJ, Bayer AS, Selsted ME: Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 1997;65:1023-1031.
9. Caccese D, Pratico D, Ghiselli A, Natoli S, Pignatelli P, Sanguigni V, Iuliano L, Violi F: Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation - role of arachidonic acid metabolism. Thromb Haemost 2000;83: 485-490.
10. Capron A, Joseph M, Ameisen JC, Capron M, Pancre V, Auriault C: Platelets as effectors in immune and hypersensitivity reactions. Int Arch Allergy Appl Immunol 1987;82:307-312.
11. Haque A, Cuna W, Bonnel B, Capron A, Joseph M: Platelet mediated killing of larvae from different filarial species in the presence of Dipetalonema viteae stimulated IgE antibodies. Parasite Immunol 1985;7:517-526.
12. Klinger MHF, Ulbricht T: Participation of human blood platelets in antimicrobial host defense. Transfus Med Hemother 2003;30:57-62.
13. Peschel A: How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002;10:179-186.
14. Dhawan VK, Bayer AS, Yeaman MR: Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2000;44:3206-3209.
15. Fowler VG Jr, McIntyre LM, Yeaman MR, Peterson GE, Barth RL, Corey GR, Wray D, Bayer AS: In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000;182: 1251-1254.
16. Wu T, Yeaman MR, Bayer AS: In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 1994;38:729-732.
17. Sjobring U, Ringdahl U, Ruggeri ZM: Induction of platelet thrombi by bacteria and antibodies. Blood 2002;100:4470-4477.
18. Ghebrehiwet B, Peerschke EI: cC1q-R (calreticulin) and gC1q-R/p33: Ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 2004;41: 173-183.
19. Peerschke EI, Ghebrehiwet B: Platelet receptors for the complement component C1q: Implications for hemostasis and thrombosis. Immunobiology 1998;199:239-249.
20. Nguyen T, Ghebrehiwet B, Peerschke EI: Staphylococcus aureus protein A recognizes platelet gC1qR/p33: A novel mechanism for staphylococcal interactions with platelets. Infect Immun 2000;68: 2061-2068.
21. Nilsson-Ekdahl K, Nilsson B: Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1. Eur J Immunol 2001;31:1047-1054.
22. Hansch GM, Gemsa D, Resch K: Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: Inhibition of the reacylation of liberated arachidonic acid. J Immunol 1985;135: 1320-1324.
23. Sims PJ, Wiedmer T: Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin Cell Biol 1995;6:275-282.
24. Spycher MO, Nydegger UE: Participation of the blood platelet in immune reactions due to platelet-complement interaction. Infusionsther Transfusionsmed 1995;22:36-43.
25. Clawson CC, White JG: Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 1971; 65:381-397.
26. Lewis JC, Maldonado JE, Mann KG: Phagocytosis in human platelets: Localization of acid phosphatase-positive phagosomes following latex uptake. Blood 1976;47:833-840.
27. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM: Host defense role of platelets: Engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002;99:4021-4029.
28. Cesbron JY, Capron A, Vargaftig BB, Lagarde M, Pincemail J, Braquet P, Taelman H, Joseph M: Platelets mediate the action of diethylcarbamazine on microfilariae. Nature 1987;325:533-536.
29. Bout D, Joseph M, Pontet M, Vorng H, Deslee D, Capron A: Rat resistance to schistosomiasis: Platelet-mediated cytotoxicity induced by C-reactive protein. Science 1986;231:153-156.
30. Ameisen JC, Joseph M, Caen JP, Kusnierz JP, Capron M, Boizard B, Wautier JL, Levy-Toledano S, Vorng H, Capron A: A role for glycoprotein IIb-IIIa complex in the binding of IgE to human platelets and platelet IgE-dependent cytotoxic functions. Br J Haematol 1986;64:21-32.
31. Crombie R, Silverstein RL, MacLow C, Pearce SF, Nachman RL, Laurence J: Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 1998;187:25-35.
32. Christin L, Wysong DR, Meshulam T, Hastey R, Simons ER, Diamond RD: Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 1998;66: 1181-1189.
33. Willcox MD, Webb BC, Thakur A, Harty DW: Interactions between Candida species and platelets. J Med Microbiol 1998;47:103-110.
34. Yeaman MR: The role of platelets in antimicrobial host defense. Clin Infect Dis 1997;25:951-968.
35. Kalvegren H, Majeed M, Bengtsson T: Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: A causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003;23:1677-1683.
36. Kerrigan SW, Douglas I, Wray A, Heath J, Byrne MF, Fitzgerald D, Cox D: A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002;100:509-516.
37. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN: Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: A new trait in microbial pathogenicity. Blood 2001;97:3790-3797.
38. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, Litt D, Fitzgerald DJ, Foster TJ, Cox D: Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: Roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A Mol Microbiol 2002;44:1033-1044.
39. Niemann S, Spehr N, Van Aken H, Morgenstern E, Peters G, Herrmann M, Kehrel BE: Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 2004;110:193-200.
40. Fox A, Harrison LC: Innate immunity and graft rejection. Immunol Rev 2000;173:141-147.
41. Kuijper PH, Gallardo Torres HI, Houben LA, Lammers JW, Zwaginga JJ, Koenderman L: P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol 1998;64:467-473.
42. Boehlen F, Clemetson KJ: Platelet chemokines and their receptors: What is their relevance to platelet storage and transfusion practice? Transfus Med 2001;11:403-417.
43. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97:1525-1534.
44. Imaizumi T, Albertine KH, Jicha DL, McIntyre TM, Prescott SM, Zimmerman GA: Human endothelial cells synthesize ENA-78: Relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol 1997;17:181-192.
45. Gear AR, Camerini D: Platelet chemokines and chemokine receptors: Linking hemostasis, inflammation, and host defense. Microcirculation 2003; 10:335-350.
46. Brodde MF, Horn M, Niemann S, Jurk K, Kehrel BE: New link between inflammation and haemostasis - alpha defensins (HNP-1/2) are strong platelet agonists. Hamostaseologie 2004;1:V65.
47. Ostrovsky L, King AJ, Bond S, Mitchell D, Lorant DE, Zimmerman GA, Larsen R, Niu XF, Kubes P: A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood 1998; 91:3028-3036.
48. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM: The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30:S294-S301.
49. Weyrich AS, Lindemann S, Zimmerman GA: The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
50. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA: Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998;95:5556-5561.
51. 3 regulates synthesis of proteins in activated human platelets. J Cell Biol 1999;144:175-184.
52. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS: Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 2001;154:485-490.
53. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J: Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem 2000;275:5987-5996.
54. Michelson AD, Barnard MR, Hechtman HB, Mac-Gregor H, Connolly RJ, Loscalzo J, Valeri CR: In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11877-11882.
55. McBane RD, Ford MA, Karnicki K, Stewart M, Owen WG: Fibrinogen, fibrin and crosslinking in aging arterial thrombi. Thromb Haemost 2000;84: 83-87.
56. Weyrich AS, Prescott SM, Zimmerman GA: Platelets, endothelial cells, inflammatory chemokines, and restenosis: Complex signaling in the vascular play book. Circulation 2002;106:1433-1435.
57. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730-1737.
58. Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y, Hosotsubo H, Kuwagata Y, Shimazu T, Sugimoto H: Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 2001;50:801-809.
59. Garlichs CD, Kozina S, Fateh-Moghadam S, Handschu R, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeisser A, Yilmaz A, Ludwig J, Neundorfer B, Daniel WG: Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003;34:1412-1418.
60. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL 3rd, Goldberg RJ, Michelson AD: Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002-1006.
61. Tschoepe D, Rauch U, Schwippert B: Platelet-leukocyte-cross-talk in diabetes mellitus. Horm Metab Res 1997;29:631-635.
62. Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, Rose MJ, Giannini S, Momi S, Spina D, O'Connor B, Gresele P, Page CP: Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 2003;112:109-118.
63. McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001;86:746-756.
64. Lang D, Dohle F, Terstesse M, Bangen P, August C, Pauels HG, Heidenreich S: Down-regulation of monocyte apoptosis by phagocytosis of platelets: Involvement of a caspase-9, caspase-3, and heat shock protein 70-dependent pathway. J Immunol 2002;168:6152-6158.
65. Issekutz AC, Ripley M, Jackson JR: Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest 1983;49:716-724.
66. Jurk K, Strey A, Janning A, Gerke V, Van Aken H, Kehrel BE: Platelets associated with monocytes modulate monocytic extravasation. Hämostaseologie 2004;1:P70.
67. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391: 591-594.
68. Lindmark E, Tenno T, Siegbahn A: Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000;20:2322-2328.
69. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL: Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003;19:9-19.
70. Danese S, de la Motte MC, Reyes BM, Sans M, Levine AD, Fiocchi C: Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: A novel pathway for immune response amplification. J Immunol 2004;172:2011-2015.
71. Diacovo TG, deFougerolles AR, Bainton DF, Springer TA: A functional integrin ligand on the surface of platelets: Intercellular adhesion molecule-2. J Clin Invest 1994;94:1243-1251.
72. Ahmad R, Menezes J, Knafo L, Ahmad A: Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol 2001;69:123-128.
73. Washington AV, Schubert RL, Quigley L, Disipio T, Feltz R, Cho EH, McVicar DW: TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and platelets. Blood 2004; 104:1042-1047.
74. Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J: Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 2000;275:20374-20381.
75. Bukharin OV, Suleimanov KG: The role of the thrombocytic cationic protein (beta-lysin) in anti-infectious protection (in Russian). Zh Mikrobiol Epidemiol Immunobiol 1997:3-6.
76. Chromek M, Tullus K, Lundahl J, Brauner A: Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun 2004;72:82-88.
77. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD: CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-252.
78. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G: Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998;80:1008-1014.
79. Schonbeck U, Libby P: The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.